NM_022124.6:c.2096A>T
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM2PM5PP3_Strong
The NM_022124.6(CDH23):c.2096A>T(p.Asp699Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/17 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D699G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_022124.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDH23 | NM_022124.6 | c.2096A>T | p.Asp699Val | missense_variant | Exon 20 of 70 | ENST00000224721.12 | NP_071407.4 | |
CDH23 | NM_001171930.2 | c.2096A>T | p.Asp699Val | missense_variant | Exon 20 of 32 | NP_001165401.1 | ||
CDH23 | NM_001171931.2 | c.2096A>T | p.Asp699Val | missense_variant | Exon 20 of 26 | NP_001165402.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The p.Asp699Val variant in CDH23 has been identified by our laboratory in the he terozygous state in 3 individuals with hearing loss in one family, though a vari ant on the remaining copy of CDH23 was not identified in any of them. It has not been identified in large population studies. A variant at the same position, p. Asp699Gly (c.2096A>G), has been reported in the compound heterozygous state with a variant of uncertain significance in 1 Dutch individual with hearing impairme nt (Seco et al. 2017). Computational prediction tools and conservation analysis suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In summary, the clinical signific ance of the p.Asp699Val variant is uncertain. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at